Role of endogenous nitric oxide in the nitric oxide donor-induced plasma extravasation of mouse skin

被引:8
作者
Fujii, E
Wada, K
Ishida, H
Yoshioka, T
Muraki, T
机构
[1] Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan
[2] Tokyo Womens Med Univ, Sch Med, Hosp Pharm, Shinjuku Ku, Tokyo 1628666, Japan
[3] Nippon Med Coll, Dept Anesthesiol, Bunkyo Ku, Tokyo 1138603, Japan
关键词
nitric oxide (NO) donor; vascular permeability; nitric oxide; prostaglandin;
D O I
10.1016/S0014-2999(99)00436-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of endogenous nitric oxide (NO) and prostanoids in the increase in microvascular permeability induced by NO donors was investigated in the mouse skin by a dye leakage method. Subcutaneous (s.c.) injection of 1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene (NOC 5), 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene (NOC 18) and sodium nitroprusside dose-dependently increased local dye leakage. While indomethacin inhibited the dye leakage elicited by these NO donors, N-G-nitro-L-arginine methyl eater (L-NAME) inhibited the effect of NOC 5 and NOC 18 but not of sodium nitroprusside. These results suggest that endogenous NO, in addition to the prostanoid biosynthesis, is involved in the dermal microvascular permeability increase induced by the NOC series NO donors. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:219 / 222
页数:4
相关论文
共 21 条
[1]  
BALDWIN AL, 1998, AM J PHYSIOL, V274, P1776
[2]  
Campbell W., 1996, Goodman and Gilman's the Pharmacological Basis of Therapeutics, Vninth, P601
[3]   Multiple controls in inflammation - Extracellular and intracellular phospholipase A(2), inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase [J].
Cirino, G .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (02) :105-111
[4]  
CLANCY RM, 1995, P SOC EXP BIOL MED, V210, P93
[5]   The use of nitric oxide donors in pharmacological studies [J].
Feelisch, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) :113-122
[6]   Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin [J].
Fujii, E ;
Irie, K ;
Ohba, K ;
Ogawa, A ;
Yoshioka, T ;
Yamakawa, M ;
Muraki, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) :475-480
[7]   ROLE OF EICOSANOIDS BUT NOT NITRIC-OXIDE IN THE PLATELET-ACTIVATING FACTOR-INDUCED INCREASE IN VASCULAR-PERMEABILITY IN MOUSE SKIN [J].
FUJII, E ;
IRIE, K ;
UCHIDA, Y ;
OHBA, K ;
MURAKI, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 273 (03) :267-272
[8]   Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin [J].
Fujii, E ;
Irie, K ;
Ogawa, A ;
Ohba, K ;
Muraki, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 297 (03) :257-263
[9]  
FUJII E, 1994, N-S ARCH PHARMACOL, V350, P361
[10]   MEDIATION BY PROSTAGLANDINS OF THE NITRIC OXIDE-INDUCED NEUROGENIC VASODILATATION IN RAT SKIN [J].
HOLZER, P ;
JOCIC, M ;
PESKAR, BA .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) :2365-2370